This inventor holds 1 USPTO granted patent. Top assignee: Tokyo Metropolitan Institute of Medical Science. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Yoshiki Takamatsu: Innovator in Neurodegenerative Disease Treatment
Introduction
Yoshiki Takamatsu is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of neurodegenerative diseases. His innovative approach focuses on the use of adiponectin receptor agonists to combat these challenging conditions.
Latest Patents
Takamatsu holds a patent for a method aimed at treating and/or preventing neurodegenerative diseases through the use of adiponectin receptor agonists. The patent, titled "Method for treating and/or preventing neurodegenerative disease by adiponectin receptor agonist," highlights a groundbreaking discovery that adiponectin receptor agonists can suppress α-synuclein aggregation, tau phosphorylation, and a decrease in proteasomal activity. This method includes administering an effective dose of elements such as adiponectin, globular adiponectin, or compounds that induce their expression. The invention also provides a screening method for identifying adiponectin receptor agonists suitable for treating neurodegenerative diseases.
Career Highlights
Yoshiki Takamatsu is affiliated with the Tokyo Metropolitan Institute of Medical Science, where he conducts his research and development work. His dedication to advancing medical science has led to the creation of effective treatment methods for neurodegenerative diseases, showcasing his commitment to improving patient outcomes.
Collaborations
Takamatsu collaborates with esteemed colleagues in his field, including Makoto Hashimoto and Kazunari Sekiyama. Their combined expertise contributes to the advancement of research and innovation in neurodegenerative disease treatment.
Conclusion
Yoshiki Takamatsu's work exemplifies the intersection of innovation and medical science. His patent for treating neurodegenerative diseases through adiponectin receptor agonists represents a significant step forward in the quest for effective therapies. His contributions continue to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile